These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 8429500)

  • 21. Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutions.
    Reubsaet JL; Beijnen JH; Bult A; van der Houwen OA; Teeuwsen J; Koster EH; Underberg WJ
    Anal Biochem; 1995 May; 227(2):334-41. PubMed ID: 7573955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation kinetics of water-insoluble lauroyl-indapamide in aqueous solutions: prediction of the stabilities of the drug in liposomes.
    Suo XB; Deng YJ; Zhang H; Wang YQ
    Arch Pharm Res; 2007 Jul; 30(7):876-83. PubMed ID: 17703741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation kinetics of a new cephalosporin derivative in aqueous solution.
    Rattie ES; Zimmerman JJ; Ravin LJ
    J Pharm Sci; 1979 Nov; 68(11):1369-74. PubMed ID: 41933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability studies of gabapentin in aqueous solutions.
    Zour E; Lodhi SA; Nesbitt RU; Silbering SB; Chaturvedi PR
    Pharm Res; 1992 May; 9(5):595-600. PubMed ID: 1608888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic study on the chemical stability of ifosfamide.
    Kaijser GP; Beijnen JH; Bult A; Hogeboom MH; Underberg WJ
    J Pharm Biomed Anal; 1991; 9(10-12):1061-7. PubMed ID: 1822174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of degradation of cefazolin and cephalexin in aqueous solution.
    Rattie ES; Guttman DE; Ravin LJ
    Arzneimittelforschung; 1978; 28(6):944-8. PubMed ID: 35181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation study of the investigational anticancer drug clanfenur.
    Sluiter C; Kettenes-van den Bosch JJ; Hop E; van der Houwen OA; Underberg WJ; Bult A
    Int J Pharm; 1999 Aug; 185(2):227-35. PubMed ID: 10460918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The aqueous stability of bupropion.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triazolines. XXI: Preformulation degradation kinetics and chemical stability of a novel triazoline anticonvulsant.
    Freeke Hamelijnck MA; Stevenson PJ; Kadaba PK; Damani LA
    J Pharm Sci; 1992 Apr; 81(4):392-6. PubMed ID: 1501079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alkali and simulated gastric and intestinal fluids on danazol stability.
    Gadkariem EA; El-Obeid HA; Abounassif MA; Ahmed SM; Ibrahim KE
    J Pharm Biomed Anal; 2003 Mar; 31(4):743-51. PubMed ID: 12644201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation kinetics of (+/-)-4'-ethyl-2-methyl-3-(1-pyrrolidinyl)propiophenone hydrochloride (HY-770) and structure-stability relationship among its analogues in aqueous solution.
    Nagata O; Terasaki T; Yada E; Sato H; Tamai I; Tsuji A
    J Pharm Sci; 1989 Jan; 78(1):57-61. PubMed ID: 2709320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution stability of ciclosidomine.
    Carney CF
    J Pharm Sci; 1987 May; 76(5):393-7. PubMed ID: 3656101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the hydrolytic behavior of tinidazole, metronidazole, and ornidazole.
    Salo JP; Yli-Kauhaluoma J; Salomies H
    J Pharm Sci; 2003 Apr; 92(4):739-46. PubMed ID: 12661060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions.
    Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
    Int J Pharm; 2013 May; 448(2):390-3. PubMed ID: 23541985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution.
    Berge SM; Henderson NL; Frank MJ
    J Pharm Sci; 1983 Jan; 72(1):59-63. PubMed ID: 6298400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of a novel tripeptide, tert-butoxycarbonyl-Tyr-Leu-Val-CH2Cl, with inhibitory effect on human leukocyte elastase in aqueous solution and in biological fluids.
    Tokumitsu H; Fukumori Y; Tsuda Y; Okada Y; Kasuya F; Igarashi K; Fukui M
    Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1845-50. PubMed ID: 9396162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of batanopride hydrochloride in aqueous solutions.
    Nassar MN; House CA; Agharkar SN
    J Pharm Sci; 1992 Nov; 81(11):1088-91. PubMed ID: 1447710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agent.
    Maclean DS; Khokhar AR; Tyle P; Perez-Soler R
    J Microencapsul; 2000; 17(3):307-22. PubMed ID: 10819419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
    Taylor R; Sunderland B; Luna G; Czarniak P
    Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.